HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 3,970.00
+60.00 (1.53%)
At close: Aug 14, 2026
HYUNDAI BIOLAND Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 135,038 | 130,505 | 119,519 | 96,720 | 99,154 | 102,802 |
Revenue Growth | 8.54% | 9.19% | 23.57% | -2.46% | -3.55% | 15.64% |
Gross Profit Gross Profit Growth | 54,571 | 53,411 | 52,687 | 39,529 | 35,361 | 36,994 |
Operating Income Operating Income Growth | 12,937 | 12,755 | 16,326 | 13,428 | 9,055 | 10,658 |
Net Income Net Income Growth | 12,480 | 252.62 | 5,703 | 8,056 | 4,764 | -11,686 |
Earnings Per Share EPS Growth | 415.95 | 8.42 | 190.10 | 268.54 | 158.81 | -389.54 |
EPS Growth | - | -95.57% | -29.21% | 69.09% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacture of Cosmetics and Pharmaceutical Raw Materials Manufacture of Cosmetics and Pharmaceutical Raw Materials Growth | 130,499 | 119,506 | 96,697 | 92,417 | 94,951 |
Chinese Cosmetics Raw Material Manufacturing Chinese Cosmetics Raw Material Manufacturing Growth | 319.26 | 241.2 | 348.78 | 8,165 | 9,200 |
Consolidation Adjustment Consolidation Adjustment Growth | -312.86 | -227.76 | -326.12 | -1,429 | -1,348 |
Total Total Growth | 130,505 | 119,519 | 96,720 | 99,154 | 102,802 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 17,265 | 23,254 | 26,500 | 23,076 | 23,074 | 14,742 |
Total Debt Total Debt Growth | 6,474 | 10,433 | 35,409 | 33,021 | 35,549 | 33,312 |
Net Cash (Debt) Net Cash Growth | 10,791 | 12,820 | -8,909 | -9,945 | -12,475 | -18,570 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 359.66 | 427.34 | -296.98 | -331.50 | -415.85 | -619.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 18,534 | 19,482 | 4,601 | 5,588 | 11,312 | 21,476 |
Capital Expenditures CapEx Growth | -2,990 | -4,002 | -3,644 | -5,767 | -3,782 | -2,261 |
Free Cash Flow Free Cash Flow Growth | 15,544 | 15,480 | 957.38 | -179.4 | 7,530 | 19,215 |
Free Cash Flow Growth | 3703.77% | 1516.86% | - | - | -60.81% | 558.47% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.41% | 40.93% | 44.08% | 40.87% | 35.66% | 35.98% |
Operating Margin | 9.58% | 9.77% | 13.66% | 13.88% | 9.13% | 10.37% |
Pretax Margin | 9.30% | 9.46% | 13.29% | 18.04% | 6.90% | -14.75% |
Profit Margin | 9.24% | 0.19% | 4.77% | 8.33% | 4.81% | -11.37% |
FCF Margin | 11.51% | 11.86% | 0.80% | -0.18% | 7.59% | 18.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.54 | 510.05 | 23.75 | 18.58 | 42.35 | - |
Forward PE | - | 7.65 | 8.50 | 37.58 | 37.58 | 37.58 |
P/FCF Ratio | 7.66 | 8.32 | 141.48 | - | 26.79 | 13.43 |
PS Ratio | 0.88 | 0.99 | 1.13 | 1.55 | 2.04 | 2.51 |